Table 1. Shift in ratio of ERα:ERβ in the presence of combined nutraceuticals.
Percentage Reduction in ERα: ERβ | MCF7 | T47D | BT483 |
---|---|---|---|
EXT 1 10% | 75.9% | 129.1% | 49.2% |
EXT 1 1% | 66.7% | 80.2% | 159.6% |
EXT 2 10% | 82.4% | -29.9% | 54.0% |
EXT 2 1% | 72.8% | -49.9% | 51.2% |